A different animal? Identifying the features of health technology assessment for developers of medical technologies (original) (raw)

Bouttell, Janet ORCID: https://orcid.org/0000-0002-4568-5483, Briggs, Andrew ORCID: https://orcid.org/0000-0002-0777-1997 and Hawkins, Neil ORCID: https://orcid.org/0000-0003-3199-221X(2020) A different animal? Identifying the features of health technology assessment for developers of medical technologies.International Journal of Technology Assessment in Health Care, 36(4), pp. 285-291. (doi: 10.1017/S0266462320000380)

Abstract

Health technology assessment (HTA) conducted to inform developers of health technologies (development-focused HTA, DF-HTA) has a number of distinct features when compared to HTA conducted to inform usage decisions (use-focused HTA). To conduct effective DF-HTA, it is important that analysts are aware of its distinct features as analyses are often not published. We set out a framework of ten features, drawn from the literature and our own experience: a target audience of developers and investors; an underlying user objective to maximize return on investment; a broad range of decisions to inform; wide decision space; reduced evidence available; earlier timing of analysis; fluid business model; constrained resources for analysis; a positive stance of analysis; and a “consumer”-specific burden of proof. This paper presents a framework of ten features of DF-HTA intended to initiate debate as well as provide an introduction for analysts unfamiliar with the field.

University Staff: Request a correction | Enlighten Editors: Update this record

Deposit and Record Details